Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Studies show that high-protein diets can help GLP-1 (glucagon-like peptide 1) medication users be more successful in their ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Initial reports of increased suicidality in GLP-1 RA users compared with the general population raised concerns about the risk for this rare but serious adverse event, given the rising popularity ...

Please provide your email address to receive an email when new articles are posted on . A review of randomized clinical trials found 33 occurrences of suicide-related behaviors with GLP-1s vs 27 ...

CordenPharma provides large-scale peptide manufacturing for the Dual GLP-1/GIP Receptor Agonist drug substance of VK2735. CordenPharma provides fill-finish for the drug candidate's subcutaneous ...

Study: Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. Image Credit: azimmytws / Shutterstock.com A ...